{"web_url": "http://www.nytimes.com/2013/12/07/business/fda-approves-pill-to-treat-hepatitis-c.html", "snippet": "The Food and Drug Administration has approved Sovaldi, from Gilead Sciences, which will let some patients be treated for a minimum of 12 weeks, but at a cost of $1,000 per daily pill.", "lead_paragraph": "The Food and Drug Administration has approved Sovaldi, from Gilead Sciences, which will let some patients be treated for a minimum of 12 weeks, but at a cost of $1,000 per daily pill.", "abstract": "Food and Drug Administration approves Sovaldi, from Gilead Sciences, pill that is expected to make treatment of hepatitis C less onerous, shorter in duration and more effective; pill will allow some patients with liver-destroying virus to do away with weekly injections and debilitating side effects.", "print_page": "1", "blog": [], "source": "The New York Times", "multimedia": [{"subtype": "wide", "url": "images/2013/12/07/business/07hepatitis-span/07hepatitis-span-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2013/12/07/business/07hepatitis-span/07hepatitis-span-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2013/12/07/business/07hepatitis-span/07hepatitis-span-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2013/12/07/business/07hepatitis-span/07hepatitis-span-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2013/12/07/business/07hepatitis-span/07hepatitis-span-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/12/07/business/07hepatitis-span/07hepatitis-span-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "headline": {"main": "F.D.A. Approves Pill to Treat Hepatitis C", "print_headline": "New Hope In Hepatitis As F.D.A. Allows Pill"}, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "5", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Liver", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Hepatitis", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Gilead Sciences Inc", "is_major": "Y", "rank": "4", "name": "organizations"}], "pub_date": "2013-12-07T00:00:00Z", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "subsection_name": null, "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "type_of_material": "News", "_id": "52a27cbb38f0d8051b44be8a", "word_count": "1004", "slideshow_credits": null}